The intracellular interplay between galectin-1 and FGF12 in the assembly of ribosome biogenesis complex
Abstract Galectins constitute a class of lectins that specifically interact with β-galactoside sugars in glycoconjugates and are implicated in diverse cellular processes, including transport, autophagy or signaling. Since most of the activity of galectins depends on their ability to bind sugar chain...
| Published in: | Cell Communication and Signaling |
|---|---|
| Main Authors: | Aleksandra Gędaj, Aleksandra Chorążewska, Krzysztof Ciura, Radosław Karelus, Dominika Żukowska, Martyna Biaduń, Marta Kalka, Małgorzata Zakrzewska, Natalia Porębska, Łukasz Opaliński |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-03-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12964-024-01558-1 |
Similar Items
FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
by: Martyna Sochacka, et al.
Published: (2022-11-01)
by: Martyna Sochacka, et al.
Published: (2022-11-01)
The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis
by: Dominika Żukowska, et al.
Published: (2024-05-01)
by: Dominika Żukowska, et al.
Published: (2024-05-01)
Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
by: Aleksandra Gedaj, et al.
Published: (2023-05-01)
by: Aleksandra Gedaj, et al.
Published: (2023-05-01)
FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner
by: Martyna Sochacka, et al.
Published: (2020-05-01)
by: Martyna Sochacka, et al.
Published: (2020-05-01)
Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor
by: Krzysztof Ciura, et al.
Published: (2025-05-01)
by: Krzysztof Ciura, et al.
Published: (2025-05-01)
Diosmin and Hesperidin Have a Protective Effect in Diabetic Neuropathy via the FGF21 and Galectin-3 Pathway
by: Birzat Emre Gölboyu, et al.
Published: (2024-09-01)
by: Birzat Emre Gölboyu, et al.
Published: (2024-09-01)
Overcoming drug resistance of cancer cells by targeting the FGF1/FGFR1 axis with honokiol or FGF ligand trap
by: Jakub Szymczyk, et al.
Published: (2024-09-01)
by: Jakub Szymczyk, et al.
Published: (2024-09-01)
Differential regulation of fibroblast growth factor receptor 1 trafficking and function by extracellular galectins
by: Marika Kucińska, et al.
Published: (2019-06-01)
by: Marika Kucińska, et al.
Published: (2019-06-01)
Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01)
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01)
Beyond ribosome biogenesis: noncoding nucleolar RNAs in physiology and tumor biology
by: Nuray Böğürcü-Seidel, et al.
Published: (2023-12-01)
by: Nuray Böğürcü-Seidel, et al.
Published: (2023-12-01)
Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus
by: Raluca Diana Ianos, et al.
Published: (2024-11-01)
by: Raluca Diana Ianos, et al.
Published: (2024-11-01)
FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs
by: Marta Poźniak, et al.
Published: (2021-07-01)
by: Marta Poźniak, et al.
Published: (2021-07-01)
N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
by: Paulina Gregorczyk, et al.
Published: (2023-07-01)
by: Paulina Gregorczyk, et al.
Published: (2023-07-01)
Correction: Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
by: Aleksandra Gedaj, et al.
Published: (2023-06-01)
by: Aleksandra Gedaj, et al.
Published: (2023-06-01)
Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells
by: Agata Lampart, et al.
Published: (2022-02-01)
by: Agata Lampart, et al.
Published: (2022-02-01)
The Ribosome Biogenesis—Cancer Connection
by: Marianna Penzo, et al.
Published: (2019-01-01)
by: Marianna Penzo, et al.
Published: (2019-01-01)
Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)
Inhibition of Ribosome Biogenesis In Vivo Causes p53-Dependent Death and p53-Independent DysfunctionSummary
by: Charles J. Cho, et al.
Published: (2025-01-01)
by: Charles J. Cho, et al.
Published: (2025-01-01)
Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
by: Yuanwei Shi, et al.
Published: (2022-05-01)
by: Yuanwei Shi, et al.
Published: (2022-05-01)
FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms
by: Jakub Szymczyk, et al.
Published: (2022-10-01)
by: Jakub Szymczyk, et al.
Published: (2022-10-01)
Differential Regulation of Nav1.1 and SCN1A Disease Mutant Sodium Current Properties by Fibroblast Growth Factor Homologous Factors
by: Ashley Frazee, et al.
Published: (2025-02-01)
by: Ashley Frazee, et al.
Published: (2025-02-01)
Focal adhesion kinase promotes ribosome biogenesis to drive advanced thyroid cancer cell growth and survival
by: Meghan D. Kellett, et al.
Published: (2025-05-01)
by: Meghan D. Kellett, et al.
Published: (2025-05-01)
Commuting to Work: Nucleolar Long Non-Coding RNA Control Ribosome Biogenesis from Near and Far
by: Victoria Mamontova, et al.
Published: (2021-07-01)
by: Victoria Mamontova, et al.
Published: (2021-07-01)
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01)
by: Fei Kong, et al.
Published: (2020-09-01)
Galectins: a potential pharmacological target
by: V. A. Serebryakova, et al.
Published: (2024-10-01)
by: V. A. Serebryakova, et al.
Published: (2024-10-01)
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
by: Daniel Compagno, et al.
Published: (2020-05-01)
by: Daniel Compagno, et al.
Published: (2020-05-01)
The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
by: Zerrin Barut, et al.
Published: (2023-09-01)
by: Zerrin Barut, et al.
Published: (2023-09-01)
A Synthetic Tetramer of Galectin-1 and Galectin-3 Amplifies Pro-apoptotic Signaling by Integrating the Activity of Both Galectins
by: Shaheen A. Farhadi, et al.
Published: (2020-01-01)
by: Shaheen A. Farhadi, et al.
Published: (2020-01-01)
Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives
by: Efstathia Pasmatzi, et al.
Published: (2019-07-01)
by: Efstathia Pasmatzi, et al.
Published: (2019-07-01)
The role of galectins in mediating the adhesion of circulating cells to vascular endothelium
by: Joseph Souchak, et al.
Published: (2024-05-01)
by: Joseph Souchak, et al.
Published: (2024-05-01)
A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal–fetal interface
by: Fangqi Zhao, et al.
Published: (2023-07-01)
by: Fangqi Zhao, et al.
Published: (2023-07-01)
Galectin-3 and galectin-1 interactions in breast cancer therapy
by: Vanitha Innocent Rani, et al.
Published: (2025-04-01)
by: Vanitha Innocent Rani, et al.
Published: (2025-04-01)
The content of soluble forms of galectins -1, -3, -4, -7, -9 in patients with renal cell cancer of various morphological types
by: Nikolay E. Kushlinskii, et al.
Published: (2024-09-01)
by: Nikolay E. Kushlinskii, et al.
Published: (2024-09-01)
FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
by: Emma Henriksson, et al.
Published: (2020-12-01)
by: Emma Henriksson, et al.
Published: (2020-12-01)
Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spread
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)
Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
by: Santiago P. Mendez-Huergo, et al.
Published: (2019-01-01)
by: Santiago P. Mendez-Huergo, et al.
Published: (2019-01-01)
Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance
by: Oshadi Edirisinghe, et al.
Published: (2024-12-01)
by: Oshadi Edirisinghe, et al.
Published: (2024-12-01)
snR30/U17 Small Nucleolar Ribonucleoprotein: A Critical Player during Ribosome Biogenesis
by: Timothy John Vos, et al.
Published: (2020-09-01)
by: Timothy John Vos, et al.
Published: (2020-09-01)
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01)
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01)
Ribosomal RNA genes shape chromatin domains associating with the nucleolus
by: Ariadna Picart-Picolo, et al.
Published: (2019-01-01)
by: Ariadna Picart-Picolo, et al.
Published: (2019-01-01)
Similar Items
-
FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
by: Martyna Sochacka, et al.
Published: (2022-11-01) -
The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis
by: Dominika Żukowska, et al.
Published: (2024-05-01) -
Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
by: Aleksandra Gedaj, et al.
Published: (2023-05-01) -
FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner
by: Martyna Sochacka, et al.
Published: (2020-05-01) -
Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor
by: Krzysztof Ciura, et al.
Published: (2025-05-01)
